Cargando…
Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy
Surgical resection is the main treatment option for most solid tumors, yet cancer recurrence after surgical resection remains a significant challenge in cancer therapy. Recent advances in cancer immunotherapy are enabling radical cures for many tumor patients, but these technologies remain challengi...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605972/ https://www.ncbi.nlm.nih.gov/pubmed/36289204 http://dx.doi.org/10.1038/s41467-022-33891-9 |